P2 purinergic receptors: modulation of cell function and therapeutic potential.
about
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyPolymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal womenPurinergic Signaling in Gut Inflammation: The Role of Connexins and PannexinsModulation of mouse embryonic stem cell proliferation and neural differentiation by the P2X7 receptorBrilliant Blue Dyes in Daily Food: How Could Purinergic System Be Affected?Purinergic signaling induces thrombospondin-1 expression in astrocytesGpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitorsSpontaneous Activity of Cochlear Hair Cells Triggered by Fluid Secretion Mechanism in Adjacent Support Cells.Identification of diadenosine triphosphate in Brugia malayi by reverse phase high performance liquid chromatography and MALDI mass spectrometry.A P2X receptor from the tardigrade species Hypsibius dujardini with fast kinetics and sensitivity to zinc and copper.Inhibition of neuronal cell death after retinoic acid-induced down-regulation of P2X7 nucleotide receptor expression.dATP/ATP, a multifunctional nucleotide, stimulates bacterial cell lysis, extracellular DNA release and biofilm development.Antagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactionsNew insights into acute lung injury.Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells.P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2Hydrostatic pressure-induced release of stored calcium in cultured rat optic nerve head astrocytes.Adenosine and bone metabolism.Aldosterone acts via an ATP autocrine/paracrine system: the Edelman ATP hypothesis revisited.Feed-forward inhibition of CD73 and upregulation of adenosine deaminase contribute to the loss of adenosine neuromodulation in postinflammatory ileitis.P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation.P2X4 receptor regulates alcohol-induced responses in microgliaA-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.Putative roles of purinergic signaling in human immunodeficiency virus-1 infectionP2 receptors: new potential players in atherosclerosisP2X(7) receptor antagonists display agonist-like effects on cell signaling proteins.Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammationAdenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.Mathematical modeling of calcium waves induced by mechanical stimulation in keratinocytes.Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y(1) and the P2Y (12) receptor and is correlated with protein expression of P2Y (12)Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.Epigenetic alteration of the purinergic type 7 receptor in salivary epithelial cells.The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.BRL37344, a β3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels.Endoplasmic reticulum/golgi nucleotide sugar transporters contribute to the cellular release of UDP-sugar signaling moleculesQuantification of extracellular UDP-galactose.Understanding the added value of g-protein-coupled receptor heteromers.Extracellular nucleotides and adenosine independently activate AMP-activated protein kinase in endothelial cells: involvement of P2 receptors and adenosine transporters.
P2860
Q24629255-5ACD51A0-09CA-4578-A0F0-0705ED83CD67Q24634398-888DA38C-04DD-4C24-98DE-0BF6494362FFQ26738433-395F2FA3-422C-4B0E-8D29-69E45D8CA601Q27334899-5B3C98E6-FC7A-44AD-8708-0B2AC6E16E8EQ28079371-DB0262CF-75BF-4891-B0BE-77F27D1BBE77Q28573378-811A2602-1F43-4B8E-B38B-454C44C6A8EAQ28594719-F8B1D779-B9AA-47FC-96B6-79F0F0E08E07Q30686396-2F2C06CC-A209-4A91-86E3-8762708004F7Q33290858-A1FCB4A4-9DCC-455E-966A-03815DC76CFEQ33401061-6A11931F-6056-4FA7-8C75-ABF1DAC4EB61Q33637655-53C167E4-D325-4439-B31E-CA352F501FCDQ33728575-90B01EBA-D0C2-4C5F-A42C-904992E091B3Q33754822-3CB07115-DAF6-46F1-B7A8-47CC028EE48CQ33822465-44AA6015-9ABF-495C-A65F-62CCED3C9BC0Q33828185-5D058A9B-9040-4EF9-B7F6-1B8C76585A3BQ33841106-CA13DE47-5642-480A-B232-13C855229A4FQ33938266-730B17BB-FA2D-404E-B3ED-50739A22EFE9Q34036039-8CD4A186-8502-4629-8F36-D9128019BFE9Q34085057-9C4F797C-9A8C-46A7-8C00-8BCDA5B5C090Q34125472-2478CA25-D5F2-42BB-8202-8FF30BD739B3Q34244930-49923432-41F2-4357-82EB-87EDA6A0A2D0Q34403131-11F516D7-4D74-406B-A897-AB44A4ED6AECQ34431207-950C3093-92CA-418A-9E17-5118AE17E023Q34446486-EAC6E8DC-08A0-4EB6-B5B9-1E0AB5A581A7Q34542194-0B7D25A5-D67C-4552-A5A4-7F8B282FAF40Q34927539-C870DC49-056C-44C6-A858-5F6BAD50C73CQ35045245-3E0968FC-95B4-4B63-9E7F-7990D726DE38Q35046009-3CC6C16C-01E4-4FFF-8FD1-9FAB449A3773Q35129799-3C4E7052-39DD-4212-A7A3-DD0010FF5532Q35130686-1AFF5F34-7F5D-4C54-8D96-4B6140BC4938Q36171090-407988A2-C1C0-48A2-9601-E224A8A04F6EQ36174036-EBA4ACDA-D588-4E08-AA12-1DD03A379268Q36310954-62E7E7DA-A40D-4D19-8AE9-74EB9F672D87Q36641966-93E19A8E-9CD7-4312-AACE-F05085A29C83Q36981077-2C9C60BB-81F6-434F-8AB5-6FBC527ECB5AQ37136287-F0F69D36-429C-4457-AA16-2B7629362951Q37169570-AF1D8C1E-326D-44B5-A7F1-8C74DF269E84Q37464273-304DB098-4B7E-4448-8932-823B6F8BEF80Q38215189-9F3D2645-7AE1-4C89-9D7E-DB8AFABB683DQ39331249-29BF2830-3D57-42C1-B6D3-1C5F37D9763E
P2860
P2 purinergic receptors: modulation of cell function and therapeutic potential.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@ast
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@en
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@nl
type
label
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@ast
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@en
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@nl
prefLabel
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@ast
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@en
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@nl
P1476
P2 purinergic receptors: modulation of cell function and therapeutic potential.
@en
P2093
Burnstock G
Williams M
P304
P407
P577
2000-12-01T00:00:00Z